Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Cambrex Advances US and European Expansions
Contributed by:
PR Newswire
Images
Tags
CAMBREX
More Like This
Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule
Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility
Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts
Cambrex Announces Sale of Drug Product Business Unit
Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing
Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities